Effect of once-yearly infusion of zoledronic acid 5 mg on spine and hip fracture reduction in postmenopausal women with osteoporosis: The HORIZON pivotal fracture trial.

被引：0
|
作者：
Black, D. M.
Boonen, S.
Cauley, J.
Delmas, P.
Eastell, R.
Reid, I.
Rosario-Jansen, T.
Caminis, J.
Zhang, J.
Hu, H.
Cummings, S.
机构：
[1] UCSF, San Francisco, CA USA
[2] Leuven Univ, Louvain, Belgium
[3] Univ Pittsburgh, Pittsburgh, PA USA
[4] Univ Lyon 1, F-69365 Lyon, France
[5] Univ Sheffield, Sheffield, S Yorkshire, England
[6] Univ Auckland, Auckland 1, New Zealand
[7] Novartis Pharmaceut, E Hanover, NJ USA
[8] UCSF, San Francisco, CA USA
[9] CPMC Res Inst, San Francisco, CA USA
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S305 / S305
页数：1
相关论文
共 50 条
  • [41] Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: Data from horizon-PFT
    Delmas, Pierre
    Bauer, Douglas
    Black, Dennis
    Boonen, Steven R.
    Cosman, Felicia
    Eastell, Richard
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S214 - S215
  • [42] ONCE-YEARLY ZOLEDRONIC ACID IMPROVED BMD IN CHINESE WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS OF DIFFERENT AGE GROUPS
    Shen, Huiyong
    Liu, Xun
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S188 - S189
  • [43] ANTIFRACTURE EFFICACY AND SAFETY OF ONCE-YEARLY ZOLEDRONIC ACID 5 MG IN MEN WITH OSTEOPOROSIS: A PROSPECTIVE, RANDOMIZED, CONTROLLED TRIAL
    Boonen, Steven
    Su, Guoqin
    Incera, Elodie
    Orwoll, Eric
    Kaufman, Jean-Marc
    Reginster, Jean-Yves
    Rizzoli, Rene
    Lippuner, Kurt
    Vanderschueren, Dirk
    Bucci-Rechtweg, Christina
    Antunez, Oscar
    Papanastasiou, Phil
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 112 - 112
  • [44] New horizons for zoledronic acid: results of the HORIZON trials in postmenopausal women with osteoporosis and after hip fracture
    Doggrell, Sheila A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (04) : 663 - 668
  • [45] Relationship of Bone Turnover Marker (PINP) and Changes in Femoral Neck Bone Mineral Density to Fracture Risk in Women with Postmenopausal Osteoporosis Treated with Once-Yearly Zoledronic Acid 5 mg (ZOL.): The HORIZON-PFT Study
    Delmas, P. D.
    Munoz, F.
    Cosman, F.
    Boonen, S.
    Black, D.
    Watts, N. B.
    Kendler, D.
    Eriksen, E. F.
    Mesenbrink, P.
    Eastell, R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S9 - S9
  • [46] Bone Mineral Density (BMD) After Hip Fracture: Variations in Response to Once-Yearly i.v. Zoledronic acid (ZOL) 5 mg
    Magaziner, J.
    Orwig, D.
    Lyles, K. W.
    Nordsletten, L.
    Boonen, S.
    Adachi, J.
    Colon-Emeric, C.
    Bucci-Rechtweg, C.
    Mesenbrink, P.
    Pieper, C.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 : S86 - S86
  • [47] EFFICACY OF ONCE-YEARLY ZOLEDRONIC ACID 5 MG IN MEN WITH OSTEOPOROSIS WITH DIFFERENT LEVELS OF SERUM TOTAL TESTOSTERONE
    Boonen, Steven
    Reginster, Jean-Yves
    Kaufman, Jean-Marc
    Lippuner, Kurt
    Zanchetta, Jose
    Langdahl, Bente
    Rizzoli, Rene
    Dimai, Hans Peter
    Eriksen, Erik
    Brixen, Kim
    Antunez, Oscar
    Su, Guoqin
    Hruska, Josef
    Vanderschueren, Dirk
    Orwoll, Eric
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S79 - S80
  • [48] Effect of zoledronic acid 5 mg on fracture risk by age and geographic region in women with postmenopausal osteoporosis: Results from horizon-pft
    Cauley, J.
    Black, D.
    Boonen, S.
    Cummings, S.
    Delmas, P.
    Eriksen, E. F.
    Hu, H.
    Eastell, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 523 - 523
  • [49] Efficacy and safety of zoledronic acid 5 mg in preventing fractures in men and women with prevalent hip fracture: The HORIZON-Recurrent Fracture Trial
    Lyles, K.
    Colon-Emeric, C.
    Magaziner, J.
    Adachi, J.
    Pieper, C.
    Hyldstrup, L.
    Mautalen, C.
    Recknor, C.
    Moore, K.
    Lavecchia, C.
    Zhang, J.
    Mesenbrink, P.
    Eriksen, E.
    Boonen, S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S16 - S16
  • [50] The effect of once-yearly zoledronic acid on hip structural and biomechanical properties derived using computed tomography (CT) in Japanese women with osteoporosis
    Ito, Masako
    Sone, Teruki
    Shiraki, Masataka
    Tanaka, Satoshi
    Irie, Chika
    Ota, Yuri
    Nakamura, Toshitaka
    BONE, 2018, 106 : 179 - 186
12345